Biggest changeInterest and Other Income, Net Year Ended December 31, 2023 2022 $ Change % Change ($ in thousands) Interest and other income, net $ 9,232 $ 1,307 $ 7,925 606.4 % As a percentage of net revenue 1.4 % 0.2 % 1.2 % Interest and other income, net increased by $7.9 million, or 606.4%, for the year ended December 31, 2023 compared to the same period in 2022 primarily due to higher interest rates on our cash and cash equivalents balance. 66 Table of Contents Provision for Income Taxes Year Ended December 31, 2023 2022 $ Change % Change ($ in thousands) Provision for income taxes $ 433 $ 497 $ (64) (12.9) % As a percentage of net revenue — % 0.1 % (0.1) % Provision for income taxes decreased $0.1 million, or 12.9%, for the year ended December 31, 2023 compared to the same period in 2022 primarily due to the 2022 establishment of a valuation allowance on our Canadian subsidiary, partially offset by higher state tax expense in 2023.
Biggest changeInterest and Other Income, Net Year Ended December 31, 2025 2024 $ Change % Change ($ in thousands) Interest and other income, net $ 8,379 $ 10,597 $ (2,218) (20.9) % As a percentage of net revenue 1.0 % 1.4 % (0.4) % Interest and other income, net decreased by $2.2 million, or 20.9%, for the year ended December 31, 2025 compared to the same period in 2024 primarily due to unfavorable fluctuations in foreign currency rates and lower interest rates on our increased cash and cash equivalents balance.
This increase was primarily driven by higher payroll-related costs, primarily from growth in our retail workforce, and investments in marketing, partially offset by a $23.2 million decrease in stock-based compensation, mostly related to the Founders Grant (as described in Note 7 to our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K).
This increase was primarily driven by higher payroll-related costs, primarily from growth in our retail workforce, and investments in marketing, partially offset by a $23.2 million decrease in stock-based compensation, mostly related to the 2021 Founders Grant (as described in Note 7 to our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K).
Adjusted EBITDA and Adjusted EBITDA Margin have limitations as analytical tools, and should not be considered in isolation, or as an alternative to, or a substitute for net loss or other financial statement data presented in our consolidated financial statements as indicators of financial performance.
Adjusted EBITDA and Adjusted EBITDA Margin have limitations as analytical tools, and should not be considered in isolation, or as an alternative to, or a substitute for net income (loss) or other financial statement data presented in our consolidated financial statements as indicators of financial performance.
(2) Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. For more information regarding our use of these measures and a reconciliation of net loss to Adjusted EBITDA and Adjusted EBITDA Margin, see the section titled "Adjusted EBITDA and Adjusted EBITDA Margin” below.
(2) Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. For more information regarding our use of these measures and a reconciliation of net income (loss) to Adjusted EBITDA and Adjusted EBITDA Margin, see the section titled "Adjusted EBITDA and Adjusted EBITDA Margin” below.
Working closely with our nonprofit partners, we have distributed glasses to people in need in more than 80 countries globally and many parts of the United States. Over 15 million more people now have the glasses they need to learn, work, and achieve better economic outcomes through our Buy a Pair, Give a Pair program.
Working closely with our nonprofit partners, we have distributed glasses to people in need in more than 80 countries globally and many parts of the United States. Over 20 million more people now have the glasses they need to learn, work, and achieve better economic outcomes through our Buy a Pair, Give a Pair program.
Cost of Goods Sold, Gross Profit, and Gross Margin Year Ended December 31, 2024 2023 $ Change % Change ($ in thousands) Cost of goods sold $ 344,481 $ 304,541 $ 39,940 13.1 % Gross profit 426,834 365,224 61,610 16.9 % Gross margin 55.3 % 54.5 % 0.8 % Cost of goods sold increased by $39.9 million, or 13.1%, for the year ended December 31, 2024 compared to the same period in 2023, and decreased as a percentage of revenue over the same period by 80 basis points, from 45.5% of revenue to 44.7% of revenue.
Cost of Goods Sold, Gross Profit, and Gross Margin Year Ended December 31, 2024 2023 $ Change % Change ($ in thousands) Cost of goods sold $ 344,481 $ 304,541 $ 39,940 13.1 % Gross profit 426,834 365,224 61,610 16.9 % Gross margin 55.3 % 54.5 % 0.8 % 62 Table of Contents Cost of goods sold increased by $39.9 million, or 13.1%, for the year ended December 31, 2024 compared to the same period in 2023, and decreased as a percentage of revenue over the same period by 80 basis points, from 45.5% of revenue to 44.7% of revenue.
Liquidity and Capital Resources Since inception, we have financed our operations primarily from net proceeds from the sale of redeemable convertible preferred stock and cash flows from operating activities. We also have access to cash from our credit facility, which remains undrawn as of December 31, 2024.
Liquidity and Capital Resources Since inception, we have financed our operations primarily from net proceeds from the sale of redeemable convertible preferred stock and cash flows from operating activities. We also have access to cash from our credit facility, which remains undrawn as of December 31, 2025.
Item 7. Management’s Discussion And Analysis Of Financial Condition And Results Of Operations You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K (“Form 10-K”).
Item 7. Management’s Discussion And Analysis Of Financial Condition And Results Of Operations You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K.
Provision for Income Taxes Year Ended December 31, 2024 2023 $ Change % Change ($ in thousands) Provision for income taxes $ 875 $ 433 $ 442 102.1 % As a percentage of net revenue 0.1 % — % 0.1 % Provision for income taxes increased $0.4 million, or 102.1%, for the year ended December 31, 2024 compared to the same period in 2023 primarily due to the change in pre-tax loss in addition to the tax effects of stock-based compensation expense, depreciation expense, and differences in tax rates in state jurisdictions.
Provision for Income Taxes Year Ended December 31, 2024 2023 $ Change % Change ($ in thousands) Provision for income taxes $ 875 $ 433 $ 442 102.1 % As a percentage of net revenue 0.1 % — % 0.1 % 63 Table of Contents Provision for income taxes increased $0.4 million, or 102.1%, for the year ended December 31, 2024 compared to the same period in 2023 primarily due to the change in pre-tax loss in addition to the tax effects of stock-based compensation expense, depreciation expense, and differences in tax rates in state jurisdictions.
Management uses Adjusted EBITDA and Adjusted EBITDA Margin: • as a measurement of operating performance because they assist us in evaluating the operating performance of our business on a consistent basis, as they remove the impact of items not directly resulting from our core operations; • for planning purposes, including the preparation of our internal annual operating budget and financial projections; • to evaluate the performance and effectiveness of our operational strategies; and • to evaluate our capacity to expand our business.
Management uses Adjusted EBITDA and Adjusted EBITDA Margin: • as a measurement of operating performance because they assist us in evaluating the operating performance of our business on a consistent basis, as they remove the impact of items not directly resulting from our core operations; 57 Table of Contents • for planning purposes, including the preparation of our internal annual operating budget and financial projections; • to evaluate the performance and effectiveness of our operational strategies; and • to evaluate our capacity to expand our business.
In addition to lower prices, we introduced simple, unified pricing (glasses starting at $95, including prescription lenses) to the eyewear market. • We’ve built a seamless shopping experience that meets customers where and how they want to shop, whether that’s on our website, on our mobile app, or in our 276 retail stores as of December 31, 2024. • We’ve crafted a holistic vision care offering that extends beyond glasses to include contacts, vision tests and eye exams, vision insurance, and more.
In addition to lower prices, we introduced simple, unified pricing (glasses starting at $95, including prescription lenses) to the eyewear market. • We’ve built a seamless shopping experience that meets customers where and how they want to shop, whether that’s on our website, on our mobile app, or in our 323 retail stores as of December 31, 2025. • We’ve crafted a holistic vision care offering that extends beyond glasses to include contacts, vision tests and eye exams, vision insurance, and more.
Critical Accounting Policies and Estimates Management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with GAAP.
Critical Accounting Policies and Estimates Management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. GAAP.
For the years ended December 31, 2024, 2023, and 2022, the amount includes $1.1 million, $0.6 million, and $0.6 million of employer payroll costs associated with releases of RSUs and option exercises, respectively.
For the years ended December 31, 2025, 2024, and 2023, the amount includes $1.6 million, $1.1 million, and $0.6 million of employer payroll costs associated with releases of RSUs and option exercises, respectively.
This discussion and other parts of this Form 10-K contain forward-looking statements, such as those relating to our plans, objectives, expectations, intentions, and beliefs, which involve risks and uncertainties. Our actual results could differ materially from those discussed in these forward-looking statements.
This discussion and other parts of this Annual Report on Form 10-K contain forward-looking statements, such as those relating to our plans, objectives, expectations, intentions, and beliefs, which involve risks and uncertainties. Our actual results could differ materially from those discussed in these forward-looking statements.
We generate revenue through selling our wide array of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. We also generate revenue from providing eye exams and vision tests, and selling eyewear accessories.
We generate revenue through selling our wide array of eyewear, including glasses, sunglasses, and contact lenses. We also generate revenue from providing eye exams and vision tests, and selling eyewear accessories.
Adjustments for inventory shrink, representing the physical loss of inventory, are estimated based on historical experience and are adjusted based upon physical inventory counts. Actual results may differ from estimates due to the quantity and mix of products in inventory, consumer preferences, and economic and market conditions.
Adjustments for inventory shrink, representing the physical loss of inventory, are estimated based on historical experience and are 66 Table of Contents adjusted based upon physical inventory counts. Actual results may differ from estimates due to the quantity and mix of products in inventory, consumer preferences, and economic and market conditions.
Recent Accounting Pronouncements See Note 2, “Summary of Significant Accounting Policies” in our consolidated financial statements included in Part II, Item 8 of this Form 10-K for a description of recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted.
Recent Accounting Pronouncements See Note 2, “Summary of Significant Accounting Policies” in our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K for a description of recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted.
We believe our existing cash and cash equivalents, funds available under our existing credit facility, and cash flows from operating activities will be sufficient to fund our operations for at least the next 12 months. Credit Facility 2022 Credit Facility In September 2022, the Company and its wholly owned subsidiary, Warby Parker Retail, Inc.
We believe our existing cash and cash equivalents, funds available under our existing credit facility, and cash flows from operating activities will be sufficient to fund our operations for at least the next 12 months. 2024 Credit Facility In February 2024, the Company and its wholly owned subsidiary, Warby Parker Retail, Inc.
Key Business Metrics and Certain Non-GAAP Financial Measures In addition to the measures presented in our consolidated financial statements, we use the following key business metrics and certain non-GAAP financial measures to evaluate our business, measure our performance, develop financial forecasts, and make strategic decisions.
Key Business Metrics and Certain Non-GAAP Financial Measures In addition to the measures presented in our consolidated financial statements, we use the following key business metrics and certain non-GAAP financial measures to evaluate our business, measure our performance, 56 Table of Contents develop financial forecasts, and make strategic decisions.
(2) Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in each of May 2024, August 2023 and May 2022 to the Warby Parker Impact Foundation, 56,938 shares of Class A common stock to charitable donor advised funds in June 2023, and 34,528 shares of Class A common stock to charitable donor advised funds in November 2022.
(2) Represents charitable expense recorded in connection with the donation of 178,572 shares of Class A common stock in each of May 2025, May 2024, and August 2023 to the Warby Parker Impact Foundation, and 56,938 shares of Class A common stock to charitable donor advised funds in June 2023.
For the year ended December 31, 2023, net cash used in investing activities was $54.7 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores and capitalized software development costs, and an investment in a private optical equipment company.
For the year ended December 31, 2024, net cash used in investing activities was $66.0 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores, investments in capitalized software development costs, and an investment in a private optical equipment company. 65 Table of Contents For the year ended December 31, 2023, net cash used in investing activities was $54.7 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores, investments in capitalized software development costs, and an investment in a private optical equipment company.
We expect SG&A to increase in absolute dollars over time and to fluctuate as a percentage of revenue due to the anticipated growth of our business, intentional investments in marketing, and changing prices of goods and services caused by inflation and other macroeconomic factors.
We expect SG&A to increase in absolute dollars over time and to fluctuate as a percentage of revenue due to the anticipated growth of our business, intentional investments in marketing, and changing prices of goods and services caused by inflation and other macroeconomic factors. SG&A is expensed in the period in which it is incurred.
Subsequent to December 31, 2024, we entered into four operating lease agreements and extended the term of one existing operating lease agreement for retail space in the U.S. Total commitments under these agreements are approximately $4.3 million.
Subsequent to December 31, 2025, we entered into ten operating lease agreements and extended the term of four existing operating lease agreement for retail space in the U.S. Total commitments under these agreements are approximately $14.3 million.
Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, decreased by 250 basis points for the year ended December 31, 2023 compared to the same period in 2022.
Gross margin, expressed as a percentage and calculated as gross profit divided by net revenue, decreased by 130 basis points for the year ended December 31, 2025 compared to the same period in 2024.
Gross profit, calculated as net revenue less cost of goods sold, increased by $24.2 million, or 7.1%, for the year ended December 31, 2023 compared to the same period in 2022, primarily due to the increase in net revenue over the same period.
Gross profit, calculated as net revenue less cost of goods sold, increased by $43.7 million, or 10.2%, for the year ended December 31, 2025 compared to the same period in 2024, primarily due to the increase in net revenue over the same period.
We had cash and cash equivalents of $254.2 million, which was primarily held for working capital purposes, and an accumulated deficit of $687.2 million as of December 31, 2024. We expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion of our business.
We had cash and cash equivalents of $286.4 million, which was primarily held for working capital purposes, and an accumulated deficit of $685.6 million as of December 31, 2025. We expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion of our business.
For the year ended December 31, 2022, net cash provided by financing activities was $3.3 million, which was primarily related to proceeds from shares issued in connection with our ESPP and stock option exercises.
For the year ended December 31, 2024, net cash provided by financing activities was $5.0 million, which was primarily related to proceeds from stock option exercises, shares issued in connection with our ESPP, and other equity activity.
Cash Flows from Investing Activities For the year ended December 31, 2024, net cash used in investing activities was $66.0 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores, investments in capitalized software development costs, and an investment in a private optical equipment company.
Cash Flows from Investing Activities For the year ended December 31, 2025, net cash used in investing activities was $67.0 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores and investments in capitalized software development costs.
Year Ended December 31, 2024 2023 2022 Active Customers ( in thousands ) 2,514 2,332 2,276 Store Count (1) 276 237 200 Adjusted EBITDA (2) ( in thousands ) $ 73,111 $ 52,352 $ 27,202 Adjusted EBITDA Margin (2) 9.5 % 7.8 % 4.5 % __________________ (1) Store Count number at the end of the period indicated.
Year Ended December 31, 2025 2024 2023 Active Customers ( in thousands ) 2,689 2,514 2,332 Store Count (1) 323 276 237 Adjusted EBITDA (2) ( in thousands ) $ 95,211 $ 73,111 $ 52,352 Adjusted EBITDA Margin (2) 10.9 % 9.5 % 7.8 % __________________ (1) Store Count number at the end of the period indicated.
The non-cash charges included $98.0 million of stock-based compensation, $31.9 million of depreciation and amortization, $3.8 million of non-cash charitable contributions, $1.6 million of non-cash impairment charges, and $0.2 million of amortization of cloud-based implementation costs.
The non-cash charges included $34.5 million of stock-based compensation, $50.3 million of depreciation and amortization, $3.4 million of amortization of cloud-based implementation costs, $2.8 million of non-cash charitable contributions, and $0.6 million of non-cash impairment charges.
(5) Represents employee severance and related costs for restructuring actions executed in October 2024 and August 2022 and charges for certain legal matters outside the ordinary course of business. Results of Operations The results of operations presented below should be reviewed in conjunction with the consolidated financial statements and notes included elsewhere in this Annual Report on Form 10-K.
(5) Primarily represents restructuring costs incurred in the second quarter of 2025 and the fourth quarter of 2024 and charges for certain legal matters outside the ordinary course of business. Results of Operations The results of operations presented below should be reviewed in conjunction with the consolidated financial statements and notes included elsewhere in this Annual Report on Form 10-K.
Financial Highlights For the years ended December 31, 2024, 2023, and 2022: • we generated net revenue of $771.3 million, $669.8 million, and $598.1 million, respectively; • we generated gross profit of $426.8 million, $365.2 million, and $341.1 million, respectively, representing a gross profit margin of 55.3%, 54.5%, and 57.0%, respectively; • we generated net loss of $20.4 million, $63.2 million, and $110.4 million, respectively; and 59 Table of Contents • we generated Adjusted EBITDA of $73.1 million, $52.4 million, and $27.2 million, respectively.
Financial Highlights For the years ended December 31, 2025, 2024, and 2023: • we generated net revenue of $871.9 million, $771.3 million, and $669.8 million, respectively; 55 Table of Contents • we generated gross profit of $470.6 million, $426.8 million, and $365.2 million, respectively, representing a gross margin of 54.0%, 55.3%, and 54.5%, respectively; • we generated net income of $1.6 million, and net loss of $20.4 million and $63.2 million, respectively; and • we generated Adjusted EBITDA of $95.2 million, $73.1 million, and $52.4 million, respectively, representing an Adjusted EBITDA Margin of 10.9%, 9.5%, and 7.8%, respectively.
“Risk Factors” of this Annual Report. Overall economic environment The nature of our business, which involves the sale of products and services that are a medical necessity for many consumers, provides some insulation from swings in consumer sentiment and general economic conditions. However, our performance and growth are still impacted by these factors.
Overall economic environment The nature of our business, which involves the sale of products and services that are a medical necessity for many consumers, provides some insulation from swings in consumer sentiment. However, our performance and growth are still subject to broader macroeconomic factors.
The following tables set forth our results of operations for the periods presented in dollars and as a percentage of net revenue: Year Ended December 31, 2024 2023 2022 ($ in thousands) Consolidated Statements of Operations Data: Net revenue $ 771,315 $ 669,765 $ 598,112 Cost of goods sold 344,481 304,541 257,050 Gross profit 426,834 365,224 341,062 Selling, general, and administrative expenses 456,946 437,220 452,265 Loss from operations (30,112) (71,996) (111,203) Interest and other income, net 10,597 9,232 1,307 Loss before income taxes (19,515) (62,764) (109,896) Provision for income taxes 875 433 497 Net loss $ (20,390) $ (63,197) $ (110,393) 62 Table of Contents Year Ended December 31, 2024 2023 2022 % of Net Revenue Consolidated Statements of Operations Data: Net revenue 100.0 % 100.0 % 100.0 % Cost of goods sold 44.7 % 45.5 % 43.0 % Gross profit 55.3 % 54.5 % 57.0 % Selling, general, and administrative expenses 59.2 % 65.3 % 75.6 % Loss from operations (3.9) % (10.8) % (18.6) % Interest and other income, net 1.4 % 1.4 % 0.2 % Loss before income taxes (2.5) % (9.4) % (18.4) % Provision for income taxes 0.1 % — % 0.1 % Net loss (2.6) % (9.4) % (18.5) % Components of Results of Operations Net Revenue We primarily derive revenue from the sales of eyewear products, optical services and accessories.
The following tables set forth our results of operations for the periods presented in dollars and as a percentage of net revenue: Year Ended December 31, 2025 2024 2023 ($ in thousands) Consolidated Statements of Operations Data: Net revenue $ 871,905 $ 771,315 $ 669,765 Cost of goods sold 401,326 344,481 304,541 Gross profit 470,579 426,834 365,224 Selling, general, and administrative expenses 475,915 456,946 437,220 Loss from operations (5,336) (30,112) (71,996) Interest and other income, net 8,379 10,597 9,232 Income (loss) before income taxes 3,043 (19,515) (62,764) Provision for income taxes 1,402 875 433 Net income (loss) $ 1,641 $ (20,390) $ (63,197) Year Ended December 31, 2025 2024 2023 % of Net Revenue Consolidated Statements of Operations Data: Net revenue 100.0 % 100.0 % 100.0 % Cost of goods sold 46.0 % 44.7 % 45.5 % Gross profit 54.0 % 55.3 % 54.5 % Selling, general, and administrative expenses 54.6 % 59.2 % 65.3 % Loss from operations (0.6) % (3.9) % (10.8) % Interest and other income, net 1.0 % 1.4 % 1.4 % Income (loss) before income taxes 0.4 % (2.5) % (9.4) % Provision for income taxes 0.2 % 0.1 % — % Net income (loss) 0.2 % (2.6) % (9.4) % Components of Results of Operations Net Revenue We primarily derive revenue from the sales of eyewear, contact lenses, and eye care.
SG&A is expensed in the period in which it is incurred. 63 Table of Contents Interest and Other Income, Net Interest and other income, net, consists primarily of interest generated from our cash and cash equivalents balances net of interest incurred on borrowings and fees on our undrawn line of credit, and is recognized as incurred.
Interest and Other Income, Net Interest and other income, net, consists primarily of interest generated from our cash and cash equivalents balances net of interest incurred on borrowings and fees on our undrawn line of credit, and is recognized as incurred.
Contractual Obligations and Commitments The following table summarizes our contractual obligations and commitments as of December 31, 2024: Payments Due by Period Total Less than 1 year 1 to 3 years 3 to 5 years More than 5 years ($ in thousands) Operating leases $ 274,882 $ 32,333 $ 97,204 $ 77,175 $ 68,170 Total $ 274,882 $ 32,333 $ 97,204 $ 77,175 $ 68,170 For additional discussion on our lease obligations, see Note 8, “Leases” in our consolidated financial statements included in Part II, Item 8 of this Form 10-K.
Contractual Obligations and Commitments The following table summarizes our contractual obligations and commitments as of December 31, 2025: Payments Due by Period Total Less than 1 year 1 to 3 years 3 to 5 years More than 5 years ($ in thousands) Operating leases $ 279,312 $ 44,137 $ 105,561 $ 71,891 $ 57,723 Total $ 279,312 $ 44,137 $ 105,561 $ 71,891 $ 57,723 For additional discussion on our lease obligations, see Note 8, “Leases” in our consolidated financial statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Cash Flows The following table summarizes our cash flows for the periods presented: Year Ended December 31, 2024 2023 2022 ($ in thousands) Net cash provided by operating activities $ 98,744 $ 60,991 $ 10,370 Net cash used in investing activities (66,032) (54,671) (60,181) Net cash provided by financing activities 4,961 2,871 3,291 Effect of exchange rates on cash (404) (882) (1,311) Net increase (decrease) in cash and cash equivalents $ 37,267 $ 8,309 $ (47,831) Cash Flows from Operating Activities Net cash provided by operating activities was $98.7 million for the year ended December 31, 2024, consisting of a net loss of $20.4 million, adjusted for $99.9 million of non-cash expenses and $19.2 million of net cash from changes in operating assets and liabilities.
Cash Flows The following table summarizes our cash flows for the periods presented: Year Ended December 31, 2025 2024 2023 ($ in thousands) Net cash provided by operating activities $ 110,785 $ 98,744 $ 60,991 Net cash used in investing activities (67,048) (66,032) (54,671) Net cash (used in) provided by financing activities (11,997) 4,959 2,871 Effect of exchange rates on cash 457 (404) (882) Net increase in cash and cash equivalents $ 32,197 $ 37,267 $ 8,309 Cash Flows from Operating Activities Net cash provided by operating activities was $110.8 million for the year ended December 31, 2025, consisting of a net income of $1.6 million, adjusted for $91.6 million of non-cash expenses and $17.6 million of net cash from changes in operating assets and liabilities.
Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the sections titled “Special Note Regarding Forward-Looking Statements” and “Risk Factors” included elsewhere in this Form 10-K. Overview We are a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise.
Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the sections titled “Special Note Regarding Forward-Looking Statements” and “Risk Factors” included elsewhere in this Annual Report on Form 10-K.
We sell products and services through our stores, website, and mobile apps. Revenue generated from eyewear includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, lens replacements, and customer charges for optional expedited shipping. Revenue generated from vision care consists of in-person eye exams and prescriptions issued through the Virtual Vision Test app.
We sell products and services through our stores, website, and mobile apps. Revenue generated from eyewear includes the sales of 59 Table of Contents prescription and non-prescription optical glasses and sunglasses, eyewear accessories, lens replacements, and customer charges for optional expedited shipping.
In addition, the obligations are required to be guaranteed in the future by certain additional domestic subsidiaries of the Company. 67 Table of Contents Other than letters of credit outstanding of $4.3 million as of both December 31, 2024 and 2023, used to secure certain leases in lieu of a cash security deposit, there were no other borrowings outstanding under the 2024 Credit Facility.
Other than letters of credit outstanding of $4.3 million as of both December 31, 2025 and 2024, used to secure certain leases in lieu of a cash security deposit, there were no other borrowings outstanding under the 2024 Credit Facility.
We define Store Count as the total number of retail stores open at the end of a given period. We believe our retail stores embody our brand, drive brand 60 Table of Contents awareness, and serve as efficient customer acquisition vehicles.
We define Store Count as the total number of retail stores open at the end of a given period. We believe our retail stores embody our brand, drive brand awareness, and serve as efficient customer acquisition vehicles. Our results of operations have been and will continue to be affected by the timing and number of retail stores that we operate.
The obligations of the Borrowers under the 2024 Credit Agreement are secured by first-lien security interests in substantially all of the assets of the Borrowers.
The obligations of the Borrowers under the 2024 Credit Agreement are secured by first-lien security interests in substantially all of the assets of the Borrowers. In addition, the obligations are required to be guaranteed in the future by certain additional domestic subsidiaries of the Company.
The increase in cost of goods sold was primarily driven by increased product and fulfillment costs associated with the growth in our contact lens offering and optical laboratory utilization, as well as an increase in store occupancy costs, including depreciation, and prescription services expenses due to new retail stores and optical exam rooms that opened in 2023.
The increase in cost of goods sold was primarily driven by increased product and fulfillment costs associated with our sales growth, particularly related to the growth in our contact lens offering and optical laboratory costs to support glasses growth, as well as increases in store occupancy costs and doctor headcount due to new retail stores.
For a definition of Adjusted EBITDA, a non-GAAP measure, and a reconciliation to the most directly comparable GAAP measure, see the section titled “Key Business Metrics and Certain Non-GAAP Financial Measures.” Factors Affecting Our Financial Condition and Results of Operations We believe that our performance and future success depend on a variety of factors that present significant opportunities for our business but also present risks and challenges that could adversely impact our growth and profitability, including those discussed below and in Part I, Item 1A.
Factors Affecting Our Financial Condition and Results of Operations We believe that our performance and future success depend on a variety of factors that present significant opportunities for our business but also present risks and challenges that could adversely impact our growth and profitability, including those discussed below and in Part I, Item 1A. “Risk Factors” of this Annual Report.
Net cash provided by operating activities was $10.4 million for the year ended December 31, 2022, consisting of a net loss of $110.4 million, adjusted for $135.5 million of non-cash expenses and $14.7 million of net cash used as a result of changes in operating assets and liabilities.
Net cash provided by operating activities was $98.7 million for the year ended December 31, 2024, consisting of a net loss of $20.4 million, adjusted for $99.9 million of non-cash expenses and $19.2 million of net cash from changes in operating assets and liabilities.
Each of the adjustments and other adjustments described in this paragraph and in the reconciliation table below help management with a measure of our core operating performance over time by removing items that are not related to day-to-day operations. 61 Table of Contents The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP measure, which is net loss: Year Ended December 31, 2024 2023 2022 ($ in thousands) Net loss $ (20,390) $ (63,197) $ (110,393) Adjusted to exclude the following: Interest and other income, net (10,596) (9,232) (1,307) Provision for income taxes 875 433 497 Depreciation and amortization expense 45,865 38,554 31,864 Asset impairment charges 816 3,230 1,647 Stock-based compensation expense (1) 48,409 71,065 98,655 Non-cash charitable donations (2) 2,196 3,191 3,770 Amortization of cloud-based software implementation costs (3) 3,704 2,895 247 ERP implementation costs (4) — 4,413 687 Other costs (5) 2,232 1,000 1,535 Adjusted EBITDA $ 73,111 $ 52,352 $ 27,202 Adjusted EBITDA Margin 9.5 % 7.8 % 4.5 % __________________ (1) Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, vesting of awards including the satisfaction of performance conditions, as well as the issuance of 48,486 shares of Class A common stock to charitable donor advised funds in February 2024.
The following table reconciles Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP measure, which is net income (loss): Year Ended December 31, 2025 2024 2023 ($ in thousands) Net income (loss) $ 1,641 $ (20,390) $ (63,197) Adjusted to exclude the following: Interest and other income, net (8,379) (10,596) (9,232) Provision for income taxes 1,402 875 433 Depreciation and amortization expense 50,280 45,865 38,554 Asset impairment charges 557 816 3,230 Stock-based compensation expense (1) 36,097 48,409 71,065 Non-cash charitable donations (2) 2,821 2,196 3,191 Amortization of cloud-based software implementation costs 3,405 3,704 2,895 System implementation costs (3) 1,883 — 4,413 Inventory write-downs (4) 2,456 — — Other costs (5) 3,048 2,232 1,000 Adjusted EBITDA $ 95,211 $ 73,111 $ 52,352 Adjusted EBITDA Margin 10.9 % 9.5 % 7.8 % 58 Table of Contents __________________ (1) Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions.
Our results of operations have been and will continue to be affected by the timing and number of retail stores that we operate. We have thoughtfully expanded our retail store footprint over the past several years. During the years ended December 31, 2024, 2023, and 2022, we opened 39, 37, and 39 net new retail stores, respectively.
We have thoughtfully expanded our retail store footprint over the past several years. During the years ended December 31, 2025, 2024, and 2023, we opened 47, 39, and 37 net new retail stores, respectively.
Cost of Goods Sold Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.
Revenue for services is recognized when the service is rendered and is recorded net of discounts. Cost of Goods Sold Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.
Selling, General, and Administrative Expenses Year Ended December 31, 2023 2022 $ Change % Change ($ in thousands) Selling, general, and administrative expenses $ 437,220 $ 452,265 $ (15,045) (3.3) % As a percentage of net revenue 65.3 % 75.6 % (10.3) % Selling, general, and administrative expenses decreased $15.0 million, or 3.3%, for the year ended December 31, 2023 compared to the same period in 2022.
Selling, General, and Administrative Expenses Year Ended December 31, 2024 2023 $ Change % Change ($ in thousands) Selling, general, and administrative expenses $ 456,946 $ 437,220 $ 19,726 4.5 % As a percentage of net revenue 59.2 % 65.3 % (6.1) % Selling, general, and administrative expenses increased $19.7 million, or 4.5%, for the year ended December 31, 2024 compared to the same period in 2023.
Revenue from products is recognized when the customer takes possession of the product, either at the point of delivery or in-store pickup, and is recorded net of returns and discounts. Revenue for services is recognized when the service is rendered and is recorded net of discounts.
Revenue generated from eye care consists of in-person eye exams and prescriptions issued through the Virtual Vision Test app. Revenue from products is recognized when the customer takes possession of the product, either at the point of delivery or in-store pickup, and is recorded net of returns and discounts.
The 2024 Credit Facility consists of a $120.0 million five-year revolving credit facility with sublimits of $15.0 million for letters of credit and $10.0 million for swingline loans.
(together, the “Borrowers”) entered into a Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders party thereto (the “2024 Credit Facility”), which replaced a previous credit facility. The 2024 Credit Facility consists of a $120.0 million five-year revolving credit facility with sublimits of $15.0 million for letters of credit and $10.0 million for swingline loans.
The decrease in gross margin was primarily driven by the sales growth of contact lenses which are sold at a lower margin than our other eyewear, increased doctor salaries, as the number of stores offering eye exams grew, and increases in store occupancy costs as a percent of revenue as we grew our store base from 200 stores as of December 31, 2022 to 237 stores as of December 31, 2023.
These impacts were partially offset by sales growth of contact lenses, which are sold at a lower margin than our other eyewear, and increased doctor headcount, as the number of stores offering eye exams grew from 194 stores as of December 31, 2023 to 236 stores as of December 31, 2024.
The changes in operating assets and liabilities were primarily driven by increases in net inventory to support the growth of our business, prepaid expenses and other assets, other non-current assets, and a net decrease in accounts payable and accrued expenses, partially offset by increases in net lease liabilities in connection with net retail leases entered into in 2022 and deferred revenue.
The changes in operating assets and liabilities were primarily driven by increases in accounts payable and lease liabilities and a decrease in inventory, partially offset by an increase in prepaid expenses and other assets.
Our historical estimates of these costs and the related provisions have not differed materially from actual results.
Our historical estimates of these costs and the related provisions have not differed materially from actual results. However, unforeseen adverse future economic and market conditions, such as those resulting from disease pandemics and other catastrophic events, could result in our actual results differing materially from our estimates.
As of December 31, 2024, 236 out of our 276 retail stores offered in-person eye exams.
As of December 31, 2025, 285 out of our 323 retail stores offered in-person eye exams, representing 88.2% of our fleet, compared to 85.5% and 81.9% as of December 31, 2024 and 2023, respectively.
For the year ended December 31, 2022, net cash used in investing activities was $60.2 million related to purchases of property and equipment to support our growth, primarily related to the build-out of new retail stores, as well as investments in our supply chain infrastructure and capitalized software development costs. 68 Table of Contents Cash Flows from Financing Activities For the year ended December 31, 2024, net cash provided by financing activities was $5.0 million, which was primarily related to proceeds from stock option exercises, shares issued in connection with our Employee Stock Purchase Plan (“ESPP”), and other equity activity.
Cash Flows from Financing Activities For the year ended December 31, 2025, net cash used in financing activities was $12.0 million, which was primarily related to cash paid for shares withheld for taxes for stock-based compensation, partially offset by proceeds shares issued in connection with our Employee Stock Purchase Plan (“ESPP”).
The growth in net revenue was primarily driven by an increase in Average Revenue per Customer, to $287 from $263 in the prior year period, as well as a 2.5% increase in Active Customers.
Driving this increase was our 47 new stores opened in 2025, a 7.0% increase in our Active Customers, and a 5.7% increase in Average Revenue per Customer to $324, from $307 in the prior year period.
These impacts were partially offset by sales growth of contact lenses, which are sold at a lower margin than our other eyewear, and increased doctor headcount, as the number of stores offering eye exams grew from 194 stores as of December 31, 2023 to 236 stores as of December 31, 2024. 64 Table of Contents Selling, General, and Administrative Expenses Year Ended December 31, 2024 2023 $ Change % Change ($ in thousands) Selling, general, and administrative expenses $ 456,946 $ 437,220 $ 19,726 4.5 % As a percentage of net revenue 59.2 % 65.3 % (6.1) % Selling, general, and administrative expenses increased $19.7 million, or 4.5%, for the year ended December 31, 2024 compared to the same period in 2023.
Selling, General, and Administrative Expenses Year Ended December 31, 2025 2024 $ Change % Change ($ in thousands) Selling, general, and administrative expenses $ 475,915 $ 456,946 $ 18,969 4.2 % As a percentage of net revenue 54.6 % 59.2 % (4.6) % Selling, general, and administrative expenses increased $19.0 million, or 4.2%, for the year ended December 31, 2025 compared to the same period in 2024.
The decrease was partially offset by increased technology costs, mainly driven by the implementation of our new ERP system, and higher compensation costs from growth in our retail workforce.
This increase was primarily driven by higher payroll related costs from growth in our retail workforce and investments in marketing, partially offset by lower stock-based 61 Table of Contents compensation, mostly related to the 2021 Founders Grant.
We also continue to diversify and expand our supply chain network, both internationally with our frame manufacturers and domestically with our wholly owned and partner optical laboratories, which we believe helps to insulate us from supply chain disruption and allowed us to continue to meet growing customer demand over the last several years while maintaining our exceptional quality and customer satisfaction standards.
Our ongoing efforts to expand our supply chain network, both through international frame manufacturing partnerships and our domestic optical laboratories, are a key strategy intended to insulate us from localized disruptions. While we continue to navigate these macroeconomic uncertainties, we remain committed to meeting growing customer demand while maintaining our exceptional quality and customer satisfaction standards.
Comparison of the Years Ended December 31, 2023 and 2022 Net Revenue Year Ended December 31, 2023 2022 $ Change % Change ($ in thousands) Net revenue $ 669,765 $ 598,112 $ 71,653 12.0 % Net revenue increased $71.7 million, or 12.0%, for the year ended December 31, 2023 compared to the same period in 2022.
We expect our provision to fluctuate based on changes in our operations, our income before taxes, and tax laws or regulations. 60 Table of Contents Comparison of the Years Ended December 31, 2025 and 2024 Net Revenue Year Ended December 31, 2025 2024 $ Change % Change ($ in thousands) Net revenue $ 871,905 $ 771,315 $ 100,590 13.0 % Net revenue increased $100.6 million, or 13.0%, for the year ended December 31, 2025 compared to the same period in 2024.
Average Revenue per Customer growth was driven by an increase in units per order as customers took advantage of our bundling promotions and also purchased contacts or eye exams along with glasses in the same transaction. 65 Table of Contents Cost of Goods Sold, Gross Profit, and Gross Margin Year Ended December 31, 2023 2022 $ Change % Change ($ in thousands) Cost of goods sold $ 304,541 $ 257,050 $ 47,491 18.5 % Gross profit 365,224 341,062 24,162 7.1 % Gross margin 54.5 % 57.0 % (2.5) % Cost of goods sold increased by $47.5 million, or 18.5%, for the year ended December 31, 2023 compared to the same period in 2022, and increased as a percentage of revenue over the same period by 250 basis points, from 43.0% of revenue to 45.5% of revenue.
Cost of Goods Sold, Gross Profit, and Gross Margin Year Ended December 31, 2025 2024 $ Change % Change ($ in thousands) Cost of goods sold $ 401,326 $ 344,481 $ 56,845 16.5 % Gross profit 470,579 426,834 43,745 10.2 % Gross margin 54.0 % 55.3 % (1.3) % Cost of goods sold increased by $56.8 million, or 16.5%, for the year ended December 31, 2025 compared to the same period in 2024, and increased as a percentage of revenue over the same period by 130 basis points, from 44.7% of revenue to 46.0% of revenue.